Browse by category

Ascletis Pharma has announced pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection studies in...

The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...

Oxford Medical Products (OMP) has announced the additional three-month clinical trial results for Sirona, a weight-loss treatment...

Researchers at the Beijing Institute of Stem Cells and Regeneration (BISCRM) and the Institute of Zoology (IOZ) have cracked the code of...

VIVUS has received market approval of QSYMIA (phentermine and topiramate extended-release capsules) CIV in the United Arab Emirates (UAE)...

Outcomes from the from REDEFINE 2, a phase 3 trial in the global REDEFINE programme, have revealed the trial achieved its primary...

The first participant has been successfully dosed in Gan & Lee Pharmaceuticals’ Phase 2 clinical trial of bofanglutide (GZR18) injection,...

The Alliance for Women's Health and Prevention's (AWHP) EveryBODY Covered campaign delivered an open letter to executives at top...

Stanford University Medical Center researchers have identified a naturally occurring molecule, BRP, which appears similar to semaglutide...

An international study led by the University of Granada (UGR) has revealed that melatonin, known for its ability to regulate the...